The Equity Method Impairment Wave
3 of 4 filers across 1 sector are flagging lower disclosed risk. First surfaced in 2025Q2; tracked through 2026Q1. Primarily a risk story (75%), with a capital overlay (25%). Recent filings describe "recognized $275 million of equity in losses of equity method investees... compared to $578 million of equity in earnings." Still gaining momentum.
Companies across energy, healthcare, and logistics are recognizing significant impairment charges and losses on equity method investments, signaling deterioration in the value or performance of their joint ventures and affiliated entities.
DISTINCT NEW FILERS PER QUARTER
✦ WHAT THE DIFF CAUGHT
Language is shifting from forward-looking monitoring of recoverability (COP) to backward-looking recognition of actual losses and impairment charges already booked (TMO, NEE, UPS).
REPRESENTATIVE SIGNAL FROM FILINGS
“recognized $275 million of equity in losses of equity method investees... compared to $578 million of equity in earnings”
Equity method investee results swung from $578 million earnings to $275 million losses, primarily due to XPLR investment losses including a $700 million impairment charge.
“$88 million impairment of an equity method investment in the second quarter of 2024”
An $88 million impairment of an equity method investment was recorded in Q2 2024.
DRIVERS